Researchers develop microneedle patch for early detection of skin cancer
最近審查：14.06.2024
所有iLive內容都經過醫學審查或事實檢查，以確保盡可能多的事實準確性。
我們有嚴格的採購指南，只鏈接到信譽良好的媒體網站，學術研究機構，並儘可能與醫學同行評審的研究相關聯。 請注意括號中的數字（[1]，[2]等）是這些研究的可點擊鏈接。
如果您認為我們的任何內容不准確，已過時或有疑問，請選擇它並按Ctrl + Enter。
Researchers from the Karolinska Institutet have developed a new method for detecting malignant melanoma. A new type of patch equipped with microneedles is able to identify the biomarker tyrosinase directly in the skin, according to a study published in Advanced Materials.
The patch is equipped with microneedles that can detect tyrosinase, an enzyme that is an important biomarker for malignant melanoma. By measuring levels of this enzyme directly in the skin, researchers can quickly identify changes associated with the disease.
“We used human tissue from healthy people. By applying tyrosinase directly to the skin, we were able to mimic skin cancer,” explains the last author of the study, Onur Parlak, Associate Professor at the Department of Solna Medicine at Karolinska Institutet.
“This is an important step forward in improving skin health monitoring, and the method can also be used to screen for other biomarkers by simply changing the design.”
Schematic illustration of epidermal microneedle sensor patch with smart probe. A demonstration of skin melanosis on the back of a patient is presented. Source: Advanced Materials (2024). DOI: 10.1002/adma.202403758
Malignant melanoma is the most serious form of skin cancer and the fastest growing cancer. The study shows that the new patch could provide an alternative to current diagnostic methods, leading to earlier detection and treatment of malignant melanoma. The researchers hope that their work will help reduce the number of procedures and improve the quality of life of patients.
“Our method is less invasive and has the potential to provide faster and more reliable results compared to traditional biopsies,” says Parlak. “Our goal is to continue to develop and improve this technique to offer a more accurate and painless diagnosis.”